Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Otr Acquisition Corp Cl A (NQ: OTRA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 9.650 (2)
Ask (Size) 10.33 (10)
Prev. Close 9.910
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics
From Comera Life Sciences Holdings, Inc.
Via Business Wire
38 Stocks Moving In Thursday's Mid-Day Session
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... 
Via Benzinga

Performance

More News

Read More
Why Is OTR Acquisition (OTRA) Stock Up Today?
Via InvestorPlace
Why OTR Acquisition Shares Are Soaring Today
Via Benzinga
71 Biggest Movers From Yesterday
Via Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
76 Biggest Movers From Yesterday
Via Benzinga
What's Going On With OTR Acquisition Stock Today?
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Target Earnings Miss Views
Via Benzinga
MULN Stock Pops 20% After Mullen Automotive Releases Preliminary Q2 Summary
Via InvestorPlace
23 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
99 Biggest Movers From Yesterday
Via Benzinga
103 Biggest Movers From Yesterday
Via Benzinga
90 Biggest Movers From Yesterday
Via Benzinga
10 Financials Stocks Moving In Monday's Intraday Session
Via Benzinga
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation
From Comera Life Sciences, Inc.
Via Business Wire
Stocks That Hit 52-Week Highs On Monday
Via Benzinga
Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo
From Comera Life Sciences, Inc.
Via Business Wire
Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration
From Comera Life Sciences, Inc.
Via Business Wire
Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
From OTR Acquisition Corp.
Via Business Wire
OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
From OTR Acquisition Corp.
Via Business Wire
Biologic Medicines-Focused Comera Life Sciences Turns To SPAC For NASDAQ Debut
Via Benzinga
Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.
From Comera Life Sciences
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.